At PromiseCare Medical Group in Hemet, California, brain stereotactic radiosurgery represents a precise and non-invasive treatment approach for brain tumors or abnormalities.
This procedure leverages high doses of radiation to target the affected area with millimeter accuracy, thereby minimizing harm to surrounding healthy tissue. Patients undergoing this treatment often complete it in a single session, with benefits unfolding over time.
These benefits range from shrinking tumors to alleviating symptoms associated with conditions such as trigeminal neuralgia. Exploring the nuances of this innovative approach reveals various types of stereotactic radiosurgery, each with distinct benefits and expectations. Ultimately, these procedures offer patients a new path to healing and an improved quality of life.
Overview
Stereotactic Radiosurgery (SRS) is a non-invasive treatment method that uses high doses of radiation to target brain tumors and abnormalities with precision and accuracy.
The process involves focusing multiple radiation beams on the tumor, delivering a precise and potent dose of radiation while minimizing exposure to healthy surrounding tissue, thus reducing the risk of complications.
Advanced 3D imaging and specialized equipment, such as linear accelerators, are used to develop the treatment plan.
SRS damages targeted cells’ DNA, inhibiting their growth and leading to gradual tumor shrinkage over time.
It’s particularly effective for various neurological conditions, including brain tumors and arteriovenous malformations.
Treatment is often completed in a single session, making it a convenient option.
The precision and effectiveness of Stereotactic Radiosurgery offer hope for those dealing with complex brain conditions, and ongoing research aims to further enhance its applications and treatment efficacy.
Types
Stereotactic radiosurgery encompasses various technologies and techniques to precisely target brain tumors and abnormalities. The Gamma Knife is a device that utilizes multiple gamma rays to treat brain tumors with high accuracy.
Linear accelerators (LINAC) are also employed, emitting high-energy X-rays to combat different tumor types. The Gamma Knife is particularly effective for small to medium-sized brain lesions, making it suitable for conditions such as vestibular schwannomas and meningiomas.
Proton beam therapy is another advanced approach that delivers targeted radiation while minimizing damage to surrounding healthy tissues. This method is used in select cases for various tumors.
Stereotactic body radiotherapy (SBRT) is a specialized technique that targets tumors in the body, often requiring multiple treatment sessions. This precise approach is effective for cancers in the lung, liver, and spine.
Advanced technologies and techniques ensure precise treatment delivery, minimizing harm to healthy surrounding tissues. Choosing the right type of stereotactic radiosurgery is essential for a safer, more effective treatment journey.
Why it’s done
Several key reasons drive the decision to undergo stereotactic radiosurgery. A brain tumor, either benign or malignant, that’s nestled deep within the brain can make traditional surgery a risky option. Abnormal blood vessels in the brain, like an arteriovenous malformation (AVM), can also lead to serious complications if left untreated.
Stereotactic radiosurgery (SRS) offers a precise solution to these complex conditions. SRS is particularly effective for treating brain tumors under 3 cm in diameter, minimizing damage to surrounding healthy tissue and reducing recovery time compared to conventional surgery.
Patients with trigeminal neuralgia, a chronic pain condition, also find relief with SRS, which targets the trigeminal nerve. Additionally, SRS is often the preferred choice for patients who aren’t candidates for traditional surgery due to health concerns or those who’ve already undergone surgery and require additional treatment for recurring tumors.
This treatment is tailored to the individual’s specific needs, prioritizing their safety and well-being. The goal of SRS is to achieve the best possible outcome.
Who it’s for
Stereotactic radiosurgery is a highly effective treatment option for patients with small to medium-sized brain tumors, typically those measuring less than 3 cm in diameter. This treatment is particularly suitable for individuals with benign or malignant tumors, such as meningiomas, vestibular schwannomas, or metastatic brain tumors.
Stereotactic radiosurgery is also effective in treating conditions like arteriovenous malformations (AVMs) and trigeminal neuralgia, precisely targeting abnormal blood vessels and nerve pain pathways.
Patients may be considered for stereotactic radiosurgery if traditional surgery isn’t a viable option due to underlying health issues, tumor location, or previous surgical history.
This treatment is ideal for individuals requiring precise targeting of tumors while minimizing damage to surrounding healthy tissue. It’s particularly effective for complex or hard-to-reach lesions, offering a safe and effective solution.
Stereotactic radiosurgery provides a precise and minimally invasive treatment option for patients with brain tumors and neurological disorders. This treatment approach prioritizes patient safety and well-being by minimizing the risk to healthy tissue.
Risks
Tackling a brain tumor or neurological disorder with stereotactic radiosurgery (SRS) is a precise and powerful approach, but like any medical treatment, it carries some level of risk. Understanding the potential side effects and complications that may arise is crucial when considering SRS.
Common side effects include temporary fatigue, scalp irritation at the treatment site, and potential hair loss in the treated area. While these effects are generally milder than those associated with conventional radiotherapy, discussing any concerns with a healthcare provider is essential.
Rare risks include pin-site bleeding or infection, as well as swelling in the brain that may require treatment with corticosteroids. In some cases, patients may experience brief, self-limiting seizures post-treatment, which are typically manageable with anti-seizure medication.
Long-term complications, such as radiation necrosis, may lead to brain swelling that requires further intervention. Additionally, tumor recurrence in different brain areas may necessitate additional SRS sessions.
Weighing these risks against the benefits of SRS and discussing any concerns with a medical team is significant to guarantee safety and well-being throughout the treatment process.
How you prepare
Preparing for brain stereotactic radiosurgery requires careful attention to detail. Fasting after midnight is crucial to ensure a smooth treatment process. Consult with your healthcare team about your regular medications, including diabetes medications, and disclose any allergies or implanted medical devices.
On the day of treatment, wear loose-fitting clothing and avoid jewelry, makeup, and accessories. A head frame will be fitted to your head, which may involve using local anesthetics for comfort. This frame ensures precise targeting of the radiation beams.
Thorough imaging studies, such as CT or MRI scans, will be conducted beforehand to accurately locate the treatment area. Following the guidance of your healthcare team and taking the necessary preparation steps is essential.
Prioritize your safety and ask any questions or concerns you may have to ensure a successful treatment outcome. Your healthcare team will work closely with you to guarantee your safety throughout the process.
What you can expect
During brain stereotactic radiosurgery, a patient is positioned on a treatment table and a lightweight head frame is attached to the head to ensure precise targeting of radiation beams. Local anesthesia is administered to numb the area, allowing the patient to remain awake and communicate with the treatment team via a microphone.
The procedure typically lasts between 30 minutes to four hours, depending on the complexity of the target area.
- Procedure duration: 30 minutes to four hours, depending on the complexity of the target area.
- Discomfort: Minor tenderness at pin sites is possible, but patients can resume normal activities, including eating and drinking, without restrictions.
- Follow-up: Imaging studies (CT or MRI) are performed within six months to assess the effectiveness of the treatment and monitor for potential side effects.
- Recovery: Patients can resume normal activities immediately, but follow-up appointments are essential to confirm the treatment’s success and address any concerns.
The treatment team closely monitors patients during and after the procedure, addressing any questions or concerns that may arise.
Results
The outcome of brain stereotactic radiosurgery unfolds like a gradual narrative, with each chapter marking a milestone in the healing process. As the journey begins, changes in the body become noticeable.
Tumors can be expected to shrink considerably over time. Benign tumors may take 18 months to 2 years to show noticeable results, while malignant tumors may shrink within a few months post-treatment. AVMs typically close off over a period of 2 years or more as the radiation thickens the abnormal blood vessels.
Imaging studies, such as MRI or CT scans, allow monitoring of the treatment’s effectiveness. Notable changes in the radiated area may take one to three years to manifest.
Pain relief may be experienced within weeks to several months after the procedure, especially in cases of trigeminal neuralgia. Follow-up care is essential for evaluating long-term outcomes and managing any late-onset complications.
Regular check-ups track progress and address concerns, ensuring safety and ideal results from radiosurgery. With time and patience, the benefits of this innovative treatment become apparent.